Agilus Diagnostics and Lucence Collaborate to Revolutionize Cancer Testing in India

Agilus Diagnostics, in partnership with Lucence, will enhance its oncology diagnostics portfolio by incorporating cutting-edge molecular testing solutions. Agilus Diagnostics has announced a strategic partnership with Lucence, a leading molecular diagnostics company, to enhance cancer detection and precision medicine in India. This collaboration will enable Agilus Diagnostics to incorporate Lucence’s cutting-edge molecular testing solutions into…

Read More

PPPM through Genetic Testing: A Patient -Centric Approach in India

Preventive, predictive, and personalized medicine tailors treatments to individual genetic profiles, enhancing patient care in India. As genetic testing adoption rises, patients benefit from early disease detection, personalized treatments, and better chronic condition management. This patient-centered approach promises targeted therapies, fewer adverse drug reactions, and improved overall health outcomes. Given this, consider the scenario of…

Read More